Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dean F Bajorin

Showing results (41-50 of 169) with videos related to

Pageof 17
Sort By:
Cancer|July 28, 2011
Progression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: endpoints for clinical trial designDarren R Feldman, Sujata Patil, Michael J Trinos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
Novel blood biomarkers of human urinary bladder cancerIman Osman, Dean F Bajorin, Tung-Tien Sun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 25, 2019
Impact of Teratoma on the Cumulative Incidence of Disease-Related Death in Patients With Advanced Germ Cell TumorsSamuel A Funt, Sujata Patil, Darren R Feldman, et al.
Cell Reports|April 12, 2018
Global Cancer Transcriptome Quantifies Repeat Element Polarization between Immunotherapy Responsive and T Cell Suppressive ClassesAlexander Solovyov, Nicolas Vabret, Kshitij S Arora, et al.
Journal of Translational Medicine|October 16, 2007
The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivoMichael T Buckley, Joanne Yoon, Herman Yee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2010
Phase II study of sunitinib in patients with metastatic urothelial cancerDavid J Gallagher, Matthew I Milowsky, Scott R Gerst, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinomaPadmanee Sharma, Yu Shen, Sijin Wen, et al.
Journal of the National Cancer Institute|February 16, 2013
Prognostic model for predicting survival of patients with metastatic urothelial cancer treated with cisplatin-based chemotherapyAndrea B Apolo, Irina Ostrovnaya, Susan Halabi, et al.
The Journal of Urology|June 10, 2022
Survival Impact of Variant Histology Diagnosis in Upper Tract Urothelial CarcinomaLucas M Nogueira, Wesley Yip, Melissa J Assel, et al.
Urology|February 27, 2007
Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tractMatthew D Galsky, Alexia Iasonos, Svetlana Mironov, et al.
Pageof 17

Showing results (41-50 of 169) with videos related to

Sort By:
Pageof 17
Cancer|July 28, 2011
Progression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: endpoints for clinical trial designDarren R Feldman, Sujata Patil, Michael J Trinos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
Novel blood biomarkers of human urinary bladder cancerIman Osman, Dean F Bajorin, Tung-Tien Sun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 25, 2019
Impact of Teratoma on the Cumulative Incidence of Disease-Related Death in Patients With Advanced Germ Cell TumorsSamuel A Funt, Sujata Patil, Darren R Feldman, et al.
Cell Reports|April 12, 2018
Global Cancer Transcriptome Quantifies Repeat Element Polarization between Immunotherapy Responsive and T Cell Suppressive ClassesAlexander Solovyov, Nicolas Vabret, Kshitij S Arora, et al.
Journal of Translational Medicine|October 16, 2007
The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivoMichael T Buckley, Joanne Yoon, Herman Yee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2010
Phase II study of sunitinib in patients with metastatic urothelial cancerDavid J Gallagher, Matthew I Milowsky, Scott R Gerst, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinomaPadmanee Sharma, Yu Shen, Sijin Wen, et al.
Journal of the National Cancer Institute|February 16, 2013
Prognostic model for predicting survival of patients with metastatic urothelial cancer treated with cisplatin-based chemotherapyAndrea B Apolo, Irina Ostrovnaya, Susan Halabi, et al.
The Journal of Urology|June 10, 2022
Survival Impact of Variant Histology Diagnosis in Upper Tract Urothelial CarcinomaLucas M Nogueira, Wesley Yip, Melissa J Assel, et al.
Urology|February 27, 2007
Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tractMatthew D Galsky, Alexia Iasonos, Svetlana Mironov, et al.
Pageof 17